CryoPort Inc (CYRX)

[ConstitutionNow]

I apologize that wasn't very nice...

[ConstitutionNow]

Go somewhere else with your 'pink sheet alert' crap. They got a patent, thats it. Means nothing.

[Trend-Setter]

"Mr. Kim Boyce, CEO of Reflect Scientific, remarked, “Reflect Scientific is now working with organizations such as the governments’ Operation Warp Speed and air carriers that have the expertise to utilize this storage system for specific customized applications.”

https://www.otcmarkets.com/stock/RSCF/news/COVID-19-Vaccine-Capable-Air-Transportation-System-Patent-Awarded-to-Reflect-Scientific-for-its-Liquid-Nitrogen-Temperat?id=282158

[H2R]

Cryoport and CCRM Fertility Enter Into Agreement

http://ir.cryoport.com/news-releases/2020/12-08-2020-133136400

Cryoport and CCRM Fertility Enter Into Agreement
BY PR Newswire
— 8:30 AM ET 12/08/2020
NASHVILLE, Tenn., Dec. 8, 2020 /PRNewswire/ -- Cryoport, Inc. ("Cryoport ( CYRX )" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced a three-year agreement with the Colorado Center for Reproductive Medicine ("CCRM"), a global pioneer in fertility science, research and advancement. Under the terms of the agreement, Cryoport's ( CYRX) temperature-controlled solutions will support CCRM's fertility treatments, including in vitro fertilization (IVF), fertility preservation, third-party reproduction and egg donation.


CCRM will utilize Cryoport's ( CYRX ) world-class temperature-controlled supply chain management and informatics platform to process cryogenic shipments of human eggs and embryos throughout its network with the mission of helping intended parents grow their families.

CCRM's network is made up of 11 centers in North America staffed by over 40 physicians, 22 PhD's and 560 dedicated employees. In addition to Cryoport ( CYRX ) assuming responsibility for all cryogenic logistics activity, Cryoport ( CYRX ) expects to extend its support to include shipments at -80°C using its C3™ line of shippers as CCRM achieves scale.

Jerrell Shelton, CEO of Cryoport ( CYRX), said, "Our relationship with CCRM is truly exciting! CCRM is a distinguished leader and pioneer in fertility science and research. It supports a national network of award-winning physicians, a full suite of fertility services, innovative technology, and cutting-edge laboratories. CCRM helps thousands of families with fertility aspirations annually. We are confident of our growth strategy for the Reproductive Medicine market as we expand our reach globally."

Jon Pardew, CEO of CCRM, said, "Partnering with Cryoport ( CYRX ) to use their world-class supply chain solutions allows us to operate more efficiently across our enterprise, mitigate risks in our supply chain and better serve the intended parents that come to us with intentions to grow their families. Cryoport's ( CYRX ) size, scale and breadth of solutions make them the right partner to ensure we offer the highest quality experience available as we expand the reach of our business."

Best of luck with your investments!

[restripe]

If the company does not get involved with the Covid shipping they should all be fired

[Trend-Setter]

RSCF on the limeligth!

COVID-19 Vaccine Capable Air Transportation System Patent Awarded to Reflect Scientific for its Liquid Nitrogen Temperature-controlled Cooling and Freezing Systems.

OREM, Utah, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announced a patent has been granted by the United States Patent Office for an ultracold shipping and storage container for transportation by air that uses liquid nitrogen technology for cooling.

The large state-of-the-art shipping system could carry many thousands of doses of vaccines and utilizes the commercially proven Cryometrix patented cooling and freezing technology that has the flexibility to provide precise temperature control across a wide range of temperatures. The system accommodates payloads ranging from those requiring conventional refrigeration to specialty products such as COVID-19 and related vaccines that may require temperatures as low as -80° centigrade (-112° Fahrenheit). Systems can be configured to provide for short or long duration shipping cycles, making it an ideal choice for cold chain management.

Mr. Kim Boyce, CEO of Reflect Scientific, remarked, “Reflect Scientific is now working with organizations such as the governments’ Operation Warp Speed and air carriers that have the expertise to utilize this storage system for specific customized applications.”

[H2R]

Pfizer COVID vaccine OK'd in the UK!

https://www.nytimes.com/2020/12/02/world/europe/pfizer-coronavirus-vaccine-approved-uk.html

That vaccine requires cold transportation: Possible market for CYRX. To be seen, but hopeful!

Best of luck with your investments!

[Trend-Setter]

Cold Chain issues? Unlike CYRX's logistic solution, a cold chain independent, thermo stable solid form vaccines is a breakthrough solution.
Google search "MACIVIVA" see how this unknown otc SEC Filer microcap, MYMX led a consortium of 5 european companies including Catalent UK (NYSE: CTLT), Bachem (SWX: BANB), to successfully develop this process. This breakthrough platform is currently applied to the company's HIV vaccine in partnership with University of Louisiana, Lafayette's Iberia Research Center under NIH funding as well as its current in-house covid vaccine development program. The company is also in partnership with Baylor College of Medicine and recently with Insel Gruppe AG in developing a covid vaccine. News is imminent on status updates.

[H2R]

Forbes: Ultra-Cold Freezer Makers To Profit From Covid-19 Vaccine Rush

https://www.forbes.com/sites/petercohan/2020/11/21/ultra-cold-freezer-makers-to-profit-from-covid-19-vaccine-rush/

Lost in all the excitement about the Covid-19 vaccine candidates seeking emergency FDA approval is a gigantic logistical challenge — the lack of a cold chain to distribute the vaccine from where it is made to where it’s injected.

A critical part of solving this logistical challenge is making enough ultra-cold freezers to keep the vaccine at below zero temperatures during that journey.

This creates investment opportunities for public and private-equity investors.

Public-equity investors should take a look at the publicly-traded makers of these ultra-cold freezers — including Thermo Fisher Scientific TMO -1.1% and Avantor. They should also consider logistics companies that provide temperature controlled shipments — such as Cryoport, McKesson and UPS.

Since none of these are pure play maker of ultra-cold freezers, perhaps the biggest beneficiaries of demand for ultra-cold freezers will be the privately held freezer makers — such as Helmer Scientific, Stirling Ultracold, PHC, and So-Lo.

However, these companies are likely constrained in meeting the demand by a lack of capital. Perhaps private equity firms should be circling these companies to provide them the capital they need to scale operations to meet the spike in demand.


Both vaccines must be kept cold. As I wrote November 16, The Pfizer vaccine must be stored and transported at minus 94 Fahrenheit; whereas the temperature of Moderna’s vaccine is a relatively balmy minus 4 degrees Fahrenheit.

Moderna’s vaccine also has a longer shelf life. Moderna’s is 30 days (versus seven which they previously thought). And the Moderna vaccine can last 12 hours at room temperature. Pfizer’s vaccine has a shorter shelf life — after it’s thawed, it can be stored refrigerated for up to five days.

$2.1 Billion Ultra-Cold Freezer Market
An ultra-cold freezer is essential for keeping the vaccine that cold while it travels from the factory to where it is injected into people.

The global ultra-low temperature freezers market is expected to grow at a 5.67% compound annual rate from $1.4 billion to about $2.1 billion in 2027, according to July 2020 Market Research Future report.

The report notes that demand has increased because of the need to store temperature-sensitive biological products storage. New opportunities have been opened up due to the “presence of major healthcare manufacturers, R&D facilities, and rising healthcare spending,” noted the report.

I am guessing that scramble for ultra-cold freezers to transport Covid-19 vaccine will accelerate that demand will above 5.67%.

While vaccine effectiveness and safety are the most critical considerations for officials trying to manage the vaccination process, sufficient supply and distribution logistics become top concerns once those first two tests are passed.

Biotech company Inovio’s CEO Joseph Kim told listeners to a November 9 conference call, “If you’re trying to deliver a vaccine ... that requires deep ‘cold chain’ like minus 70 or minus 80 Celsius, you are not going to be able to do that in most of the regions and most of the countries outside the U.S. And even the U.S., it is going to be a significant heavy lift to distribute those vaccines,” reported ctpost.

Should You Invest in Thermo Fisher Or Avantor?
Publicly-traded companies Thermo Fisher Scientific and Avantor make ultra-cold freezers which range in price from $12,000 to nearly $30,000, noted ctpost.

Neither company is a pure-play — they make most of their money from other products. Given the companies’ results during the pandemic, I think ThermoFisher has the edge.

ThermoFisher
$28.9 billion (last 12 months’ sales) Waltham, Mass.-based Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents.

The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (15%); life science solutions (36%); and lab products and services (40%). ThermoFisher does not report its ultra-freezer revenues.

ThermoFisher — whose stock has risen 38% this year to $451 a share as of November 20 — is benefiting from the pandemic. DowJones reported that the company expects 20% growth in 2020 revenue to about $30.52 billion and a 48% pop ion adjusted earnings to $18.27 a share for the year

In October, ThermoFisher said it expects 29% organic growth in the quarter ending December 2020 with an expected $1.75 billion in Covid-19 response revenue, noted Dow Jones.

Avantor
$6.1 billion (last 12 months’ sales) Radnor, Penn.-based Avantor sells materials, consumables, equipment and instrumentation to biopharma, healthcare, education and government, and advanced technologies and applied materials industries.

Its stock has risen about 40% in 2020 to nearly $26 a share, according to Morningstar. Its revenue grew 2% to $4.6 billion in the first nine months of 2020. Sadly, it does not report its ultra-cold storage freezer revenues — which are likely a small proportion of its total sales.

Are Cold-Storage Shippers a Better Bet?
Three logistics companies say they have what it takes to ship Covid-19 vaccines — with some limitations. A McKesson MCK +2.1% spokesman said “the wholesaler will ship Covid-19 vaccines requiring refrigeration to minus 20 Celsius,” according to the Wall Street Journal. That will be cold enough for the Moderna vaccine but not the Pfizer one.

Cryoport, Nashville, Tenn.-based wholesaler, has been providing temperature-controlled shipments for pharma companies since 2018. It already uses technology that can keep livestock animal vaccines at minus 196 degrees for about a month, noted the Journal. Cryoport is exploring whether that technology could be adapted to ship the Covid-19 vaccine.

Wes Wheeler, president of UPS Healthcare, told the Journal that United Parcel Service UPS +1.7% plans “by October to finish construction of its freezer farms filled with mobile freezer units in Louisville, Ky., and the Netherlands to serve as stopover points during distribution or while awaiting regulatory decisions.”

Those freezers — which can hold as many as 48,000 vials each, can be configured to hold a vaccine at between minus 85 and minus 20 degrees Celsius. UPS could handle the Pfizer and Moderna vaccines.

Investing Private Equity in Ultra Cold Freezer Makers
If you happen to run a private equity firm, I wonder whether it would be worth looking into investing in privately-held makers of ultra-cold freezers, according to ctpost, such as PHC Holdings — which expects a 50% increase in orders this year, according to Mainichi — and Cincinnati, Ohio-based So-Low.

Others include Noblesville, IN-based Helmer Scientific and Athens, Ohio-based Stirling Ultracold are adding to their workforce and expanding capacity, according to the Irish Sun.

Demand for ultra-cold freezers is going to soar over the next year as the world scales up to ship Covid-19 vaccines. Unless you run a private equity firm, buying ThermoFisher shares could be the best — though imperfect — way to profit from this demand growth.

Peter Cohan

[H2R]

Cryoport: Potential Commercial Benefits from COVID-19 Vaccines (CYRX, Buy, $46.43)

SoS also sees it:

https://smithonstocks.com/cryoport-potential-commercial-benefits-from-covid-19-vaccines-cyrx-buy-46-43/

I'm keeping my shares for the medium term, that's for sure. Plus, it's house money at this stage. All good.

[H2R]

CYRX as a potential COVID Vaccine shipping system.

Along the lines I was thinking about:

For an alternative, Deutsche Post AG's DPWGn.DE DHL has been using Cyroport's capsule containers, which use liquid nitrogen to keep goods as cool as -150C for up to 10 days to support clinical vaccine trials, said Patricia Cole, DHL Global Forwarding's global head of temperature management solutions.

https://newsfilter.io/articles/airlines-scramble-to-prepare-for-ultra-cold-covid-19-vaccine-distribution-be03d5158a6c206dbe0db5dfaafe1d8c

Complete article below:

PARIS/FRANKFURT (Reuters) - Airlines are scrambling to prepare ultra-cold shipping and storage facilities to transport COVID-19 vaccines developed by Pfizer and Moderna, whose doses, which require deep freezing, are likely to be among the first to be distributed.

A recent survey by an air cargo association and a drug shippers' group found only 15% of industry participants felt ready to transport goods near the minus 70 degrees Celsius (-94°F) required by the Pfizer Inc PFE.N vaccine, while around 60% could meet Moderna Inc's MRNA.O less stringent -20°C requirement.

Typically, airlines use containers with cooling materials such as dry ice to transport pharmaceutical products, but some don’t have temperature controls, making products susceptible to unforeseen events such as flight delays.

Airlines are now considering options ranging from a large plug-in freezer that can cost about as much as a small car to a multi-layered canister that uses liquid nitrogen to ship vaccines requiring a deep freeze.

The potential demand for such high-end packaging has helped shares of cold container specialists such as Cryoport Inc CYRX.O and Germany-based va-Q-tec VQTG.DE more than double in recent months.

"With direct contracts with five temperature-controlled container manufacturers, Korean Air has secured sufficient quantities of containers. For now, we are in the process of signing contracts with other container manufacturers," a Korean Air 003490.KS spokesperson said.

Air France-KLM AIRF.PA said it was gearing up for a test run with one of the drugmakers - it declined to say which - that will see dummy samples shipped at ultra-low temperatures, likely via Amsterdam's Schiphol airport.

The drill will use boxes carrying as many as 5,000 doses each, all cooled by dry ice, Air France-KLM special cargo manager Béatrice Delpuech told Reuters. Later shipments may also use larger ultra-cold containers rented from va-Q-tec.

“They need to validate the entire logistics chain from end to end, including the air freight segment,” Delpuech said. “We have a dedicated task force examining every step of the process with all our teams, to make sure there are no hitches anywhere.”

DRY ICE LIMITS
But one difficulty with vaccine transport is that airplanes can only carry a limited amount of dry ice - frozen carbon dioxide - as it turns into gas over time, displacing the breathable air in the cabin.

All widebody planes can carry a maximum of around 1 tonne of dry ice in refrigerated and insulated containers, according to a DHL white paper on vaccine transport.

“Depending on the type of aircraft, there are usually not more than a few containers on board at the same time,” said Joachim von Winning, chief executive of Air Cargo Community Frankfurt.

For an alternative, Deutsche Post AG's DPWGn.DE DHL has been using Cyroport's capsule containers, which use liquid nitrogen to keep goods as cool as -150C for up to 10 days to support clinical vaccine trials, said Patricia Cole, DHL Global Forwarding's global head of temperature management solutions.

Although it is relatively a small-scale solution, with only hundreds of vials in each container, broader preparations have already begun.

Pfizer, which is working with DHL, FedEx Corp FDX.N and United Parcel Service Inc UPS.N for vaccine distribution in the United States, said on Monday it has launched a pilot delivery programme in four states to help it refine its nationwide and global shipping plan.

The U.S. drugmaker has also developed temperature-controlled and GPS-enabled boxes that use dry ice to keep its vaccine at around -70C for up to 10 days.

But cold-chain solutions providers such as Sweden’s Envirotainer say so-called active containers, which use electric motors to cool their contents, are safer and more cost-effective.

A Envirotainer spokesman said that its fleet of active temperature-controlled containers was twice that of its competitors and that it was preparing to increase its capacity by 50%.

Va-Q-tec also said this month that it would significantly expand its container fleet over the coming months in anticipation of orders COVID-19 vaccine transport.

Airlines have become more reliant on cargo for revenue this year as passenger numbers plunged amid pandemic-related travel restrictions.

Accenture’s Seabury Consulting estimates the global roll-out of a vaccine will generate 65,000 tonnes of air freight, which is five times the air vaccine trade in 2019.

But airlines think the potential for the vaccine to allow a return to normal travel is most important, KLM chief executive Pieter Elbers said at a CAPA Centre for Aviation event on Nov. 11.

“I think overall for the entire industry, the vaccine is going to be much more important than the cargo revenues it would bring,” he said.

Reporting by Laurence Frost in Paris and Ilona Wissenbach in Frankfurt; additional reporting by Lisa Baertlein in Los Angeles, Toby Sterling in Amsterdam, Alexander Cornwell in Dubai, Heekyong Yang in Seoul, Helena Soderpalm in Stockholm and Jamie Freed in Sydney; writing by Jamie Freed; Editing by Miyoung Kim and Gerry Doyle

[discipline]

Thanks COLD. Please tell ColdAsIce to come back and give us his thoughts.
I'm re-reading his old posts right now, the guy was brilliant. He should remember me.

I think you're right, the stock price seems a little high right now.
The big run in the last 5 market days, where it's gone from $40 to $60, has to be the result of the earnings conference call with the analysts they had on Nov. 5. The CFO basically said he thought the sales could be at $650 million to $750 million range, in the next 4/5 years. This was a huge statement from a company that has never before given any sales guidance or earnings guidance. Also, sales increased 19% from the 2nd quarter, another big leap. Both of the acquisitions of CRYOPDP (spelling?) and MVE were in the middle of the 3rd quarter, so I expect the 4th quarter numbers to really also jump. During the call, all the officers were reading from prepared statements that were very well put together, I assume by some marketing genius. It was impressive.

I originally bought 270,000 shares at low prices in 2007, and thought I was set for life. I went to Larry Stambaugh's first board of directors annual meeting in Costa Mesa in October 2009, where he lied and said without the 10/1 reverse split, the company would close down in a week. Well we're still here. Stambaugh only wanted the reverse split so he could get a $900,000 bonus to pay off one of his ex-wives. She was sending faxes to the company's fax machine telling everyone Larry was a deadbeat-ex-husband and a deadbeat-Dad who wasn't paying his bills,
I then went to Stambaugh's 2nd annual meeting in October 2010, when only 2 other shareholders showed up because nobody cared anymore and Stambaugh was driving the company into the ground with no sales and a scheme to send all our cash to his current wife's private company in the form of "recruiting expenses."

After Mr. Shelton's second reverse split a couple years later, my 270,000 shares was down to around 2,700. But based on all the great research and information from ColdAsIce, I managed to get another few thousand shares in the $4-5 dollar range, and now I'm sitting on easy street. I would love to hear from him.

[H2R]

Nearing the 52 weeks high. Other folks must have similar thoughts with the cold chain and Pfizer's COVID-19 vaccine.

Best of luck with your investments!

[COLD]

I think it was my brother who was cold as ice. We were both heavily invested in this during the dark years. At one point I was probably down about 50k that was invested in private placements. I had at least 50,000 warrants expire worthless but somehow I had about 4600 warrants with a strike price of $3.57 that I exercised. So after years of pain the worm turned but it was not without many sleepless nights. This board used to be really active and now, ironically, it's dead and the stock is exploding. I plan on holding for at least 5 years. I think one reason for the current uptrend has to do with the cold storage companies that CYRX purchased with a huge investment from Blackstone. I believe CYRX currently has 26 COVID vaccines or therapies in their mix. A lot of these, including Pfizer's vaccine (I don't know if they are working with Pfizer) need to be transported and stored at very cold (- 70-90C). This is a big problem because most hospitals do not have the cold storage containers and dealing with dry ice is a big problem. Not only that - think of the logistics nightmare transporting the vaccines that survive for only 5 days. CYRX has spent years and millions of dollars developing a very sophisticated transport and logistics system world wide to deal with this. I'm pleasantly surprised at the huge rise in the stock price. Last time I checked 20% of the stock was shorted so maybe it's a short squeeze. The RSI is off the chart so I think the stock will come back down but it does it's probably a good time to buy.

Best
COLD

[discipline]

Does anyone know what happened to "ColdAsIce"? He posted in 2007 under the name "Cryoport" then in 2008 to 2018 under "ColdAsIce". He was really knowledgable about the mechanisms of Cryoport Inc. and cold shipping.
He was the guy who kept me in this stock through all the dark days.
We've been through the days of CEO Peter Berry, who spent more time at "wine tastings" then he did at Cryoport. Then Criminal Larry Stambaugh's reign of terror, when he illegally funnelled all the Company's cash to his 4th wife's "employment recruiting agency" until he was fired and security finally walked him off the premises.

This stock has really taken off and now the board is dead. Maybe nobody's talking to not jinx it.

I would love to hear from "ColdAsIce". I think his last post was 2018.
I've made a fortune on this thing and would like to thank him.

[H2R]

Pfizer COVID-19 vaccine will need to be stored (hence transported) at low temperatures.

"How to Ship a Vaccine at –80°C, and Other Obstacles in the Covid Fight"

https://www.nytimes.com/2020/09/18/business/coronavirus-covid-vaccine-cold-frozen-logistics.html

This may look like a great opportunity for CYRX, esp. after this year's acquisition in Europe, when Pfizer has European (German & Belgium) and US COVID-19 vaccine plants.

I have not read anything about the possible impact on CYRX, but it could be a possibility.

Best of luck with your investments!

[ernie44]

THINK CYRX used to be CYRIF and before that INCE

[H2R]

Up 400% in 2 years! Not my worst investment :)

Sometimes, I do get lucky!

Best of luck with your investments!

[H2R]

CYRX[..] most want to own for the next five years,

SoS after the acquisition of MVE.

https://smithonstocks.com/cryoport-update-cyrx-42-24-buy/

I'm staying in for a while :)

Best of luck with your investments!

[H2R]

SoS Assessment of Revenue

Cryoport reported that in 2019,

* MVE generated revenue of approximately $84 million and

* CRYOPDP had approximately $47 million of revenue.

Hence the combined sales of the three companies for 2019 was $165 million.

CRYOPDP and MVE have been growing in low double digits, but were impacted in 2020 by COVID. Management has not given any guidance on their growth in 2020 or potential in 2021. Just for the sake of illustration, let’s assume that revenues of CRYOPDP and MVE are flat in 2020 and grow at 10% in 2021. This would suggest revenues for the new Cryoport in 2020 would be $172 million and in 2021 would increase to $200 million.

https://smithonstocks.com/cryoport-update-cyrx-42-24-buy/

Best of luck with your investments!

[H2R]

CYRX completes acquisition of MVE

“The acquisitions are also expected to expand Cryoport’s total addressable market, provide our clients’ with expanded end-to-end support across the cell and gene therapy value chain and enhance our innovation pipeline.”

“We are excited by the prospects of our future as we vigorously work to fulfill and maintain our mission of being the life sciences industry’s pre-eminent choice for temperature-controlled supply chain solutions supporting life and health on earth.”

https://www.gasworld.com/cryoport-completes-acquisition-of-mve-from-chart/2019895.article

Best of luck with your investments!

[gigi21]

Sorry, Not sure how or why, but I do know that I got the recommendation for the NWBO purchase on this board. Very knowledgeable posters here. I am always looking for the next best thing. Thanks,

[H2R]

Hi gigi21,

I'm not hyper :) (me, it's H2R). But cool you got some NWBO. I've been in it since 2013, hoping for a big day before the end of September.

Cheers!

[gigi21]

Hi Hyper. Glad to see you here. I did buy some NWBO on your information at .28 and again at .30 Thanks for the lead, up a bunch on that one too. Yes I am still in here at CYRX letting it ride.

[H2R]

I've enjoyed your posts on the NWBO board. You provide real information.

On this side, we had a couple of interesting acquisitions, which provided fuel for PPS action. It's been a very good year thus far and percentage wise, CYRX is my best stock pick of the last three years. Now that I'm playing with house money (I recouped my initial investment), I'm letting it ride.

Good to see you are doing well with CYRX.

Best of luck with your investments!

[hyperopia]

Hi All. Been a while. I got a message today that CYRX hit my price target, but I think I'll just let it ride. This board was dead for so long, that I forgot about it. Nice to see some of you are still around.

[H2R]

SoS had a follow up article after the announcement of the second acquisition:

Cryoport: My Take on the Recent Acquisitions and Strong Move in the Stock (CYRX, Buy, $55.50)

https://smithonstocks.com/cryoport-my-take-on-the-recent-acquisitions-and-strong-move-in-the-stock-cyrx-buy-55-50/

Best of luck with your investments!

[H2R]

SoS take on the French acquisition:

Cryoport: The Acquisition of CRYOPDP Looks to Be a Major Coup (CYRX, $36.51, Buy)

https://smithonstocks.com/cryoport-the-acquisition-of-cryopddp-looks-to-be-a-major-coup-cyrx-36-51-buy/

Boy, he was not wrong! That article is dated AUG 24, 2020. Within a couple of days, it was over $50! I can see why based given his Smith on Stock's argumentation and projections!

Best of luck with your investments!

[H2R]

And it keeps climbing!!! This is my top stock this year thus far.
Best of luck with your investments!

[whytestocks]

Just In: $CYRX Why Cryoport Stock Is Up 39% Since Yesterday and Chart Industries Stock is Down

Shares of  Cryoport  (NASDAQ: CYRX) are surging on Aug. 26, up 26.5% as of 11:54 a.m. EDT. Combined with yesterday's big gains, the cryobiological logistics company's shares have gained almost 40% in the past two days.  The big gains come after yesterday's announcement that Cry...

Read the whole news CYRX - Why Cryoport Stock Is Up 39% Since Yesterday and Chart Industries Stock is Down

[H2R]

Sold some after getting a 4 bagger (close to a 5 :) !
Playing with house money now :)

Best of luck with your investments!

[H2R]

Another good day in $CYRX land.

Best of luck with your investments!

[Frayed Knot]

$52!!! Yes. OOPS, my bad, now $55, high of $56.

So happy I held my shares.

Just wished I had bought more last Oct. Dang.

Beautiful run, doing a happy dance, that's for sure!

[whytestocks]

NEWS: $CYRX Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries

NASHVILLE, Tenn. , Aug. 25, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced it has signed an agreement to acquire MVE Biological Solutions ("M...

Read the whole news CYRX - Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries

[H2R]

On the heels of the other recent acquisition mentioned by whytestocks on this MB,

NASHVILLE, Tenn., Aug. 21, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the expansion of its global supply chain network and services by signing an agreement to acquire CRYOPDP, a leading global provider of innovative temperature-controlled logistics solutions to the clinical research, pharmaceutical and cell and gene therapy markets, headquartered in Paris, France.

[H2R]

Cryoport to Acquire MVE Biological Solutions from Chart Industries for $320 Million

BY MT Newswires
— 8:23 AM ET 08/25/2020
08:23 AM EDT, 08/25/2020 (MT Newswires) -- Cryoport ( CYRX ) , a provider of supply chain solutions for the life sciences industry, has agreed to acquire MVE Biological Solutions, a provider of cryogenic storage and transportation solutions, from Chart Industries, Inc. ( GTLS ) in an all-cash transaction valued at $320 million.

To fund the acquisition, Cryoport ( CYRX ) is receiving a $275 million investment from funds managed by Blackstone's (BX) Blackstone Tactical Opportunities. Blackstone will purchase $250 million of a newly designated perpetual 4% series C convertible preferred stock with a purchase price of $1,000 per share, and $25 million of the company's common stock. The remainder of the purchase price for the acquisition will be paid from Cryoport's ( CYRX ) cash balance.

CYRX in acquisition mode. I worked for a hypergrowth company in the early 2000's. Acquisitions was the fuel.

Best of luck with your investments!

[H2R]

So that's the reason for today's PPS action?

CRYOPDP has over 220 dedicated employees located in 22 global facilities in 12 countries and has more than 25 years of experience serving the life sciences and Healthcare industries, providing customized and turnkey transport solutions, with over 300,000 high-value, time critical annual shipments globally. CRYOPDP covers a significant portion of the healthcare temperature-controlled supply chain including packaging, pick-pack kit preparation, premium services and specialty courier support.

CYRX strikes while it's hot!!!

Best of luck with your investments!

[ConstitutionNow]

Am I missing something here? Cryopdp has similar revenues as Cryoport, however we are buying them for around US $58million? Are we tremendously overvalued here at $1.5+ BILLION?

[whytestocks]

BREAKING NEWS: $CYRX Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP

NASHVILLE, Tenn. , Aug. 21, 2020 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the expansion of its global supply chain network and services by s...

Find out more CYRX - Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP

[ConstitutionNow]

Hey Lazer, still checking in here I see. I must have been in on the same private placement, as had those warrants also(same exercise price as tradeable warrants), of course it was a bit of a cluster trying to get them exercised and deposited in a trading account. Cyrx has been good to me also, rough road but well worth it.

Where we go from here is hard to predict, I can only imagine there are a bunch of shorts at these prices, if the mm's push a little harder could have a nice squeeze, although my gut tells me they will prevail once more and drive us back to the mid 20's.

The coming election could also have major ramifications for the market as a whole also...

[laser777]

CYRX was very good to me, but I held it for a long, long time.
I bought it when that idiot Stambaugh was the CEO. He was an idiot. Couple reverse splits, but held on and bought into the offering, which turned out to be a good deal. They adjusted you for the reverse split.
I am now, as you are, waiting on NWBO, one of their customers.
Hope I have the same luck there.

[H2R]

You kind of scored, didn't you!

I tend to with folks best of luck with their investments, but it looks like you don't even need luck :))

Cheers!

[laser777]

I had some non trade able warrants, and the exercise price was $3.57.
They also had to be held at for 6 months after exercise.

[H2R]

I am not doing my DD much on CYRX these days! Letting it run unchecked...

Total # shares: 38,101,000 (38M). 1 or 2 M exercised warrants would add 2 to 5 %, that's not insignificant. It would bring in some cash (not sure what the exercised price is though), not sure how much of a drag it might be on the PPS.

Thanks so much for the heads up.

[ConstitutionNow]

You know, the tradeable warrants(cyrxw) expire this month. I cant remember how many exist yet but a million or two rings a bell. I'm assuming they will get exercised which will add that many common shares to the float. No idea if it will affect the price but the market cap will reflect the added shares. Just an fyi.

[ConstitutionNow]

Hey H,
Yeah I'm stunned at the strength here, I keep looking at money flow, macd, volume weighted macd, and they were all into overbought territory last week already.

Made my first purchase in 2013, and last around 2015. Something that's been consistent, is after these hard run ups to new highs, it consolidates down significantly. I admit I hedged too early by selling calls, but I'm pretty confident by November this we will revisit 25 or so(give or take 5 bucks:).

I did sell a quarter of my shares over last couple days as cryoport has become about 80 percent of my portfolio and have to bite the bullet and pay taxes sooner or later! I've moved a bunch to atrs as Antares has to be one of the most underappreciated biotechs around?!? I may sell more if we have a 'blow off top' type run.

Anyway I look at it, I've made a pile of money if I sell now, and would be happy even if it goes to 40 without me!

Best of luck to you too!

[H2R]

Hey ConstitutionNow,

This is becoming my best performing stock! The upward pressure keeps going. Pretty amazing.

Not sure if I should take some benefits now and let it run waiting for my other big bets to come in, but looking good here.

The last update from them was back in May. I have not seen any new news since then and the 1 month, 3 months, 6 months PPS are all bullish (can't remember if it's an O'Neal type indicator, or if he went with 13 weeks etc.).

Any thoughts as to this continued upward trend?

Best of luck with your investments!

[H2R]

Thanks for the thoughts again! Great to hear from you.

I haven't looked at CYRX in a while (I'm a bit overfocused on NWBO and CVM, they both "should" - Ha!- be announcing data lock "soon" and that will drive some PPS action I believe. They are both super risky though!).

It's good to see the PPS where it is now. My average share price is around $10. I still like the number of Ph III coming in to play. Out of 62, how many will be approved and continue with CYRX in the next year or two: 5, 10, 20? It should still drive the PPS up. It may take a while.

In the meantime, other stocks I have may be moving one way or the other, biotech is not for the faints of heart, that's for sure. I may lose a ton of money or make a ton in the next 6 months.

I may take action on CYRK based on other stocks movements. For now, I'm staying put.

As always, I appreciate your thoughts.

Best of luck with your investments!

[ConstitutionNow]

Hey H2R, interesting strength being shown here. I'm still amazed at the market valuation here and still believe we visit lower prices(16 to 20ish) in the next 6 months again.

Have you ever used stocktwits dot com? The last person to post shows an interesting chart analysis that indicates cryoport running to around 37 before the next major consolidation. With the recent strength I'm starting to think he may be in the ball park....time will tell. Hope all is well.

[H2R]

20% down. Ouch! Still way ahead, but that took a bite!!

Best of luck with your investments!